Featured Research

from universities, journals, and other organizations

When helper cells aren't helpful

Date:
May 30, 2010
Source:
American Journal of Pathology
Summary:
Current research suggests that T helper-type 1 cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis, a mouse model of multiple sclerosis, by suppressing Th17 cells.

Current research suggests that T helper-type 1 (Th1) cells, previously thought to mediate autoimmunity, may actual inhibit the development of experimental immune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS), by suppressing Th17 cells.

The related report by Wildbaum et al. appears in the June 2010 issue of The American Journal of Pathology.

MS is believed to be an autoimmune disorder, where damage to the nervous system is caused by the patient's own immune system. Th1 cells, which secrete high levels of the inflammatory mediator interferon-γ(IFN-γ), have been previously implicated as being pathogenic in autoimmune diseases such as MS. More recent data, however, suggests that antigen-specific T cells that produce the molecule IL-17 (Th17 cells) initiate the inflammatory process in EAE.

As IFN-γ suppresses Th17 cell development, a group led by Dr. Nathan Karin at the Rappaport Family Institute for Research in the Medical Sciences hypothesized that IFN-γ-expressing T cells may serve as regulatory cells to block the development of autoimmunity. They discovered that EAE development depended on the death of these antigen-specific IFN-γ-expressing regulatory cells at early stages of disease and that inhibiting the killing of these cells at early stages of EAE suppressed disease development. In addition, overexpression of IFN-γ in EAE-mediating T cells caused them to act instead as antigen-specific regulatory cells. Thus, early suppression of Th17 cells may block the development of autoimmunity.

Wildbaum et al conclude that "recent data from humans suggest that Th17 cells play an important role in the pathogenesis of a diverse group of immune-mediated diseases, including psoriasis, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease, and that in these diseases Th17 cells are likely to be the driver cells even at advanced stages. This makes the challenge of understanding the regulatory mechanisms underlying Th17 function highly applicable, even at advanced stages of these diseases."

Dr. Karin states that "the vast majority of multiple sclerosis patients develop a form of diseases know as relapsing-remitting disease, or relapsing-progressive disease, in which attacks are followed by remissions. It is believed that regulatory cells play a major role in restraining the progression of disease." In future studies, Dr. Karin's group will "explore the hypothesis that these new types of regulatory cells indeed participate in the regulation of multiple sclerosis, and if so, determine the mechanistic basis of their entry to program cell death just before the disease accelerates. In particular, [they will attempt to define] what makes these regulatory cells more susceptible to entering the process of programmed cell death compared with other cell types? This may lead to the development of novel ways to treat multiple sclerosis and other inflammatory autoimmune diseases."

This study was supported by grants from the Israel Science Foundation (ISF), The Israel Ministry of Health Chief Scientist, and the by the L. Aronberg Research Fund in Neurology.


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wildbaum G, Zohar Y, Karin N. Antigen-specific CD25-Foxp3-IFN-γhigh CD4+ T cells restrain the development of experimental allergic encephalomyelitis by suppressing Th17 cells. American Journal of Pathology, 2010; 176: 2764-2775

Cite This Page:

American Journal of Pathology. "When helper cells aren't helpful." ScienceDaily. ScienceDaily, 30 May 2010. <www.sciencedaily.com/releases/2010/05/100524072910.htm>.
American Journal of Pathology. (2010, May 30). When helper cells aren't helpful. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2010/05/100524072910.htm
American Journal of Pathology. "When helper cells aren't helpful." ScienceDaily. www.sciencedaily.com/releases/2010/05/100524072910.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Fauci: Ebola Protocols to Focus on Training

Fauci: Ebola Protocols to Focus on Training

AP (Oct. 20, 2014) Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, says he expects revised CDC protocols on Ebola to focus on training, observation and ensuring health care workers are more protected. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins